[Correspondence] Bioresorbable coronary scaffolds should disappear faster
Why do bioresorbable scaffolds represent a revolution in percutaneous coronary intervention? Permanent coronary stents for a temporary situation (ie, scaffolding during healing) can lead to another disease such as in-stent restenosis or thrombosis, or neoatherosclerosis, due to a foreign body in the artery. Permanent metallic caging of the coronary artery increases the risk of in-stent restenosis or thrombosis. In 1998, the idea of transitory scaffolding emerged: a trial demonstrated the safety in humans of the first fully bioresorbable scaffold.